5 Key Takeaways
-
1
Siloton secured an £8.4 million Innovate UK contract to accelerate development and clinical evaluation of its handheld GiraffeOCT retinal imaging system.
-
2
GiraffeOCT uses miniaturized photonic chip technology to create a portable OCT device designed for in-clinic and at-home use.
-
3
Siloton will collaborate with Sunderland Specialist Eye Hospital on clinical trials, while York Health Economics Consortium analyzes potential NHS cost savings.
-
4
The contract runs for 2 years and could shorten Siloton’s development timeline by up to 2 years, according to the company.
-
5
Clinical performance, cost-effectiveness, and suitability for home monitoring remain to be evaluated.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
